Annual report

Period2024-01-01 → 2024-12-31

Filed2025-03-24

StandardJapan GAAP

ConsolidatedYes

Data checks24 of 24 passed

Key figures · 147

Metric	Value	Period	Scope	Source row
Revenue	¥84.1bn	2024-01-01 → 2024-12-31	Cons.	Net sales
Revenue	¥84.9bn	2023-01-01 → 2023-12-31	Cons.	Net sales
Revenue	¥81.1bn	2022-01-01 → 2022-12-31^d	Cons.	Net sales (5-year summary)
Revenue	¥78.6bn	2021-01-01 → 2021-12-31^d	Cons.	Net sales (5-year summary)
Revenue	¥77.7bn	2020-01-01 → 2020-12-31^d	Cons.	Net sales (5-year summary)
Operating income	¥3.4bn	2024-01-01 → 2024-12-31	Cons.	Operating income
Operating income	¥3.6bn	2023-01-01 → 2023-12-31	Cons.	Operating income
Ordinary income	¥3.6bn	2024-01-01 → 2024-12-31	Cons.	Ordinary income
Ordinary income	¥3.7bn	2023-01-01 → 2023-12-31	Cons.	Ordinary income
Ordinary income	−¥645m	2022-01-01 → 2022-12-31^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥1.3bn	2021-01-01 → 2021-12-31^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥2.2bn	2020-01-01 → 2020-12-31^d	Cons.	Ordinary income loss (5-year summary)
Profit before tax	¥3.6bn	2024-01-01 → 2024-12-31	Cons.	Income before income taxes
Profit before tax	¥3.6bn	2023-01-01 → 2023-12-31	Cons.	Income before income taxes
Net income (owners)	¥2.7bn	2024-01-01 → 2024-12-31	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥3.4bn	2023-01-01 → 2023-12-31	Cons.	Profit loss attributable to owners of parent
Net income (owners)	−¥1.3bn	2022-01-01 → 2022-12-31^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥299m	2021-01-01 → 2021-12-31^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥1.1bn	2020-01-01 → 2020-12-31^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income	¥2.7bn	2024-01-01 → 2024-12-31	Cons.	Profit loss
Net income	¥3.4bn	2023-01-01 → 2023-12-31	Cons.	Profit loss
Total assets	¥55.7bn	at 2024-12-31	Cons.	Assets
Total assets	¥55.4bn	at 2023-12-31	Cons.	Assets
Total assets	¥55.5bn	at 2022-12-31^d	Cons.	Total assets (5-year summary)
Total assets	¥52.3bn	at 2021-12-31^d	Cons.	Total assets (5-year summary)
Total assets	¥51.7bn	at 2020-12-31^d	Cons.	Total assets (5-year summary)
Total liabilities	¥31.3bn	at 2024-12-31	Cons.	Liabilities
Total liabilities	¥33.2bn	at 2023-12-31	Cons.	Liabilities
Net assets / equity	¥24.5bn	at 2024-12-31	Cons.	Net assets
Net assets / equity	¥22.2bn	at 2023-12-31	Cons.	Net assets
Net assets / equity	¥19.6bn	at 2022-12-31^d	Cons.	Net assets
Net assets / equity	¥22.0bn	at 2021-12-31^d	Cons.	Net assets (5-year summary)
Net assets / equity	¥22.1bn	at 2020-12-31^d	Cons.	Net assets (5-year summary)
Cash and deposits	¥887m	at 2024-12-31	Cons.	Cash and deposits
Cash and deposits	¥828m	at 2023-12-31	Cons.	Cash and deposits
Cash & equivalents	¥882m	at 2024-12-31	Cons.	Cash and cash equivalents
Cash & equivalents	¥824m	at 2023-12-31	Cons.	Cash and cash equivalents
Cash & equivalents	¥894m	at 2022-12-31^d	Cons.	Cash and cash equivalents
Cash & equivalents	¥986m	at 2021-12-31^d	Cons.	Cash and cash equivalents (5-year summary)
Cash & equivalents	¥910m	at 2020-12-31^d	Cons.	Cash and cash equivalents (5-year summary)
Operating cash flow	¥4.3bn	2024-01-01 → 2024-12-31	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥4.6bn	2023-01-01 → 2023-12-31	Cons.	Net cash provided by used in operating activities
Operating cash flow	−¥860m	2022-01-01 → 2022-12-31^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥1.6bn	2021-01-01 → 2021-12-31^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥4.8bn	2020-01-01 → 2020-12-31^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Investing cash flow	−¥1.3bn	2024-01-01 → 2024-12-31	Cons.	Net cash provided by used in investment activities
Investing cash flow	¥11m	2023-01-01 → 2023-12-31	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥4.0bn	2022-01-01 → 2022-12-31^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥2.9bn	2021-01-01 → 2021-12-31^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥3.5bn	2020-01-01 → 2020-12-31^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Financing cash flow	−¥2.9bn	2024-01-01 → 2024-12-31	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥4.7bn	2023-01-01 → 2023-12-31	Cons.	Net cash provided by used in financing activities
Financing cash flow	¥4.8bn	2022-01-01 → 2022-12-31^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	¥1.4bn	2021-01-01 → 2021-12-31^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥1.5bn	2020-01-01 → 2020-12-31^d	Cons.	Net cash provided by used in financing activities (5-year summary)
EPS (basic)	¥47.39	2024-01-01 → 2024-12-31	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥58.3	2023-01-01 → 2023-12-31	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥-21.22	2022-01-01 → 2022-12-31^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥5.03	2021-01-01 → 2021-12-31^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥19.26	2020-01-01 → 2020-12-31^d	Cons.	Basic earnings loss per share (5-year summary)
Net assets per share	¥414.62	at 2024-12-31	Cons.	Net assets per share (5-year summary)
Net assets per share	¥367.3	at 2023-12-31	Cons.	Net assets per share (5-year summary)
Net assets per share	¥305.21	at 2022-12-31^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥336.73	at 2021-12-31^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥336.41	at 2020-12-31^d	Cons.	Net assets per share (5-year summary)
Equity ratio	42.4%	at 2024-12-31	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	38.6%	at 2023-12-31	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	32.0%	at 2022-12-31^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	38.3%	at 2021-12-31^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	38.7%	at 2020-12-31^d	Cons.	Equity to asset ratio (5-year summary)
ROE	12.1%	2024-01-01 → 2024-12-31	Cons.	Rate of return on equity (5-year summary)
ROE	17.3%	2023-01-01 → 2023-12-31	Cons.	Rate of return on equity (5-year summary)
ROE	1.5%	2021-01-01 → 2021-12-31^d	Cons.	Rate of return on equity (5-year summary)
ROE	5.8%	2020-01-01 → 2020-12-31^d	Cons.	Rate of return on equity (5-year summary)
Employees	808	at 2024-12-31	Cons.	Number of employees
Employees	787	at 2023-12-31	Cons.	Number of employees
Employees	803	at 2022-12-31^d	Cons.	Number of employees
Employees	879	at 2021-12-31^d	Cons.	Number of employees
Employees	908	at 2020-12-31^d	Cons.	Number of employees
Revenue	¥3.0bn	2024-01-01 → 2024-12-31	Standalone	Net sales
Revenue	¥2.7bn	2023-01-01 → 2023-12-31	Standalone	Net sales
Revenue	¥2.3bn	2022-01-01 → 2022-12-31^d	Standalone	Net sales (5-year summary)
Revenue	¥2.5bn	2021-01-01 → 2021-12-31^d	Standalone	Net sales (5-year summary)
Revenue	¥2.5bn	2020-01-01 → 2020-12-31^d	Standalone	Net sales (5-year summary)
Operating income	¥1.8bn	2024-01-01 → 2024-12-31	Standalone	Operating income
Operating income	¥1.6bn	2023-01-01 → 2023-12-31	Standalone	Operating income
Ordinary income	¥1.8bn	2024-01-01 → 2024-12-31	Standalone	Ordinary income
Ordinary income	¥1.5bn	2023-01-01 → 2023-12-31	Standalone	Ordinary income
Ordinary income	¥956m	2022-01-01 → 2022-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥1.2bn	2021-01-01 → 2021-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥1.0bn	2020-01-01 → 2020-12-31^d	Standalone	Ordinary income loss (5-year summary)
Profit before tax	¥1.8bn	2024-01-01 → 2024-12-31	Standalone	Income before income taxes
Profit before tax	¥1.7bn	2023-01-01 → 2023-12-31	Standalone	Income before income taxes
Net income	¥1.5bn	2024-01-01 → 2024-12-31	Standalone	Profit loss
Net income	¥1.4bn	2023-01-01 → 2023-12-31	Standalone	Profit loss
Net income	¥766m	2022-01-01 → 2022-12-31^d	Standalone	Net income loss (5-year summary)
Net income	¥839m	2021-01-01 → 2021-12-31^d	Standalone	Net income loss (5-year summary)
Net income	¥716m	2020-01-01 → 2020-12-31^d	Standalone	Net income loss (5-year summary)
Total assets	¥38.0bn	at 2024-12-31	Standalone	Assets
Total assets	¥37.9bn	at 2023-12-31	Standalone	Assets
Total assets	¥38.5bn	at 2022-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥34.8bn	at 2021-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥33.4bn	at 2020-12-31^d	Standalone	Total assets (5-year summary)
Total liabilities	¥18.8bn	at 2024-12-31	Standalone	Liabilities
Total liabilities	¥19.6bn	at 2023-12-31	Standalone	Liabilities
Net assets / equity	¥19.2bn	at 2024-12-31	Standalone	Net assets
Net assets / equity	¥18.3bn	at 2023-12-31	Standalone	Net assets
Net assets / equity	¥16.7bn	at 2022-12-31^d	Standalone	Net assets
Net assets / equity	¥16.6bn	at 2021-12-31^d	Standalone	Net assets (5-year summary)
Net assets / equity	¥16.2bn	at 2020-12-31^d	Standalone	Net assets (5-year summary)
Cash and deposits	¥104m	at 2024-12-31	Standalone	Cash and deposits
Cash and deposits	¥107m	at 2023-12-31	Standalone	Cash and deposits
EPS (basic)	¥26.64	2024-01-01 → 2024-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥24.53	2023-01-01 → 2023-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥12.95	2022-01-01 → 2022-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥14.13	2021-01-01 → 2021-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥12.03	2020-01-01 → 2020-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
Dividend per share	¥10	2024-01-01 → 2024-12-31	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥8	2023-01-01 → 2023-12-31	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥5	2022-01-01 → 2022-12-31^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2021-01-01 → 2021-12-31^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2020-01-01 → 2020-12-31^d	Standalone	Dividend paid per share (5-year summary)
Net assets per share	¥336.51	at 2024-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥314.32	at 2023-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥287.56	at 2022-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥279.87	at 2021-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥272.03	at 2020-12-31^d	Standalone	Net assets per share (5-year summary)
Equity ratio	50.5%	at 2024-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	48.3%	at 2023-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	43.5%	at 2022-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	47.8%	at 2021-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	48.4%	at 2020-12-31^d	Standalone	Equity to asset ratio (5-year summary)
ROE	8.2%	2024-01-01 → 2024-12-31	Standalone	Rate of return on equity (5-year summary)
ROE	8.2%	2023-01-01 → 2023-12-31	Standalone	Rate of return on equity (5-year summary)
ROE	4.6%	2022-01-01 → 2022-12-31^d	Standalone	Rate of return on equity (5-year summary)
ROE	5.1%	2021-01-01 → 2021-12-31^d	Standalone	Rate of return on equity (5-year summary)
ROE	4.4%	2020-01-01 → 2020-12-31^d	Standalone	Rate of return on equity (5-year summary)
Shares issued	65,586,196	at 2024-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2023-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2022-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2021-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2020-12-31^d	Standalone	Total number of issued shares (5-year summary)
Employees	21	at 2024-12-31	Standalone	Number of employees
Employees	24	at 2023-12-31	Standalone	Number of employees
Employees	28	at 2022-12-31^d	Standalone	Number of employees
Employees	37	at 2021-12-31^d	Standalone	Number of employees
Employees	44	at 2020-12-31^d	Standalone	Number of employees

Periods use the dates stated in the filing. ^d = earlier-year period dated by calendar; ^v = that date confirmed by the company's own earlier filing.

Segments · 81

Segment	Item	Period	Value
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	depreciation	2024-01-01 → 2024-12-31	¥0
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue	2024-01-01 → 2024-12-31	¥99m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue external	2024-01-01 → 2024-12-31	¥88m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue intersegment	2024-01-01 → 2024-12-31	¥10m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment assets	at 2024-12-31	¥42m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2024-01-01 → 2024-12-31	¥13m
Reconciling Itemsreconciling	capex	2024-01-01 → 2024-12-31	¥118m
Reconciling Itemsreconciling	depreciation	2024-01-01 → 2024-12-31	¥103m
Reconciling Itemsreconciling	revenue	2024-01-01 → 2024-12-31	−¥25m
Reconciling Itemsreconciling	revenue intersegment	2024-01-01 → 2024-12-31	−¥25m
Reconciling Itemsreconciling	segment assets	at 2024-12-31	¥5.4bn
Enzymatic Medicinereportable segment	capex	2024-01-01 → 2024-12-31	¥282m
Enzymatic Medicinereportable segment	depreciation	2024-01-01 → 2024-12-31	¥250m
Enzymatic Medicinereportable segment	employees	at 2024-12-31	117 pure
Enzymatic Medicinereportable segment	revenue	2024-01-01 → 2024-12-31	¥4.2bn
Enzymatic Medicinereportable segment	revenue external	2024-01-01 → 2024-12-31	¥4.2bn
Enzymatic Medicinereportable segment	segment assets	at 2024-12-31	¥3.8bn
Enzymatic Medicinereportable segment	segment profit	2024-01-01 → 2024-12-31	¥534m
Liquorreportable segment	capex	2024-01-01 → 2024-12-31	¥1.2bn
Liquorreportable segment	depreciation	2024-01-01 → 2024-12-31	¥1.3bn
Liquorreportable segment	employees	at 2024-12-31	669 pure
Liquorreportable segment	revenue	2024-01-01 → 2024-12-31	¥78.7bn
Liquorreportable segment	revenue external	2024-01-01 → 2024-12-31	¥78.7bn
Liquorreportable segment	revenue intersegment	2024-01-01 → 2024-12-31	¥15m
Liquorreportable segment	segment assets	at 2024-12-31	¥40.5bn
Liquorreportable segment	segment profit	2024-01-01 → 2024-12-31	¥2.3bn
Real Estatereportable segment	capex	2024-01-01 → 2024-12-31	¥20m
Real Estatereportable segment	depreciation	2024-01-01 → 2024-12-31	¥281m
Real Estatereportable segment	employees	at 2024-12-31	1 pure
Real Estatereportable segment	revenue	2024-01-01 → 2024-12-31	¥1.1bn
Real Estatereportable segment	revenue external	2024-01-01 → 2024-12-31	¥1.1bn
Real Estatereportable segment	segment assets	at 2024-12-31	¥6.0bn
Real Estatereportable segment	segment profit	2024-01-01 → 2024-12-31	¥604m
—segment total	capex	2024-01-01 → 2024-12-31	¥1.5bn
—segment total	depreciation	2024-01-01 → 2024-12-31	¥1.8bn
—segment total	revenue	2024-01-01 → 2024-12-31	¥84.0bn
—segment total	revenue external	2024-01-01 → 2024-12-31	¥84.0bn
—segment total	revenue intersegment	2024-01-01 → 2024-12-31	¥15m
—segment total	segment assets	at 2024-12-31	¥50.3bn
—segment total	segment profit	2024-01-01 → 2024-12-31	¥3.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	depreciation	2023-01-01 → 2023-12-31	¥0
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue	2023-01-01 → 2023-12-31	¥87m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue external	2023-01-01 → 2023-12-31	¥87m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment assets	at 2023-12-31	¥39m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2023-01-01 → 2023-12-31	¥12m
Reconciling Itemsreconciling	capex	2023-01-01 → 2023-12-31	¥42m
Reconciling Itemsreconciling	depreciation	2023-01-01 → 2023-12-31	¥100m
Reconciling Itemsreconciling	revenue	2023-01-01 → 2023-12-31	−¥14m
Reconciling Itemsreconciling	revenue intersegment	2023-01-01 → 2023-12-31	−¥14m
Reconciling Itemsreconciling	segment assets	at 2023-12-31	¥4.7bn
Enzymatic Medicinereportable segment	capex	2023-01-01 → 2023-12-31	¥341m
Enzymatic Medicinereportable segment	depreciation	2023-01-01 → 2023-12-31	¥247m
Enzymatic Medicinereportable segment	revenue	2023-01-01 → 2023-12-31	¥3.5bn
Enzymatic Medicinereportable segment	revenue external	2023-01-01 → 2023-12-31	¥3.5bn
Enzymatic Medicinereportable segment	segment assets	at 2023-12-31	¥3.7bn
Enzymatic Medicinereportable segment	segment profit	2023-01-01 → 2023-12-31	¥328m
Liquorreportable segment	capex	2023-01-01 → 2023-12-31	¥1.2bn
Liquorreportable segment	depreciation	2023-01-01 → 2023-12-31	¥1.2bn
Liquorreportable segment	revenue	2023-01-01 → 2023-12-31	¥78.8bn
Liquorreportable segment	revenue external	2023-01-01 → 2023-12-31	¥78.8bn
Liquorreportable segment	revenue intersegment	2023-01-01 → 2023-12-31	¥14m
Liquorreportable segment	segment assets	at 2023-12-31	¥40.7bn
Liquorreportable segment	segment profit	2023-01-01 → 2023-12-31	¥2.6bn
Real Estatereportable segment	capex	2023-01-01 → 2023-12-31	¥13m
Real Estatereportable segment	depreciation	2023-01-01 → 2023-12-31	¥284m
Real Estatereportable segment	revenue	2023-01-01 → 2023-12-31	¥1.2bn
Real Estatereportable segment	revenue external	2023-01-01 → 2023-12-31	¥1.2bn
Real Estatereportable segment	segment assets	at 2023-12-31	¥6.3bn
Real Estatereportable segment	segment profit	2023-01-01 → 2023-12-31	¥618m
Starch For Processingreportable segment	capex	2023-01-01 → 2023-12-31	¥2m
Starch For Processingreportable segment	depreciation	2023-01-01 → 2023-12-31	¥7m
Starch For Processingreportable segment	revenue	2023-01-01 → 2023-12-31	¥1.3bn
Starch For Processingreportable segment	revenue external	2023-01-01 → 2023-12-31	¥1.3bn
Starch For Processingreportable segment	segment profit	2023-01-01 → 2023-12-31	−¥6m
—segment total	capex	2023-01-01 → 2023-12-31	¥1.5bn
—segment total	depreciation	2023-01-01 → 2023-12-31	¥1.8bn
—segment total	revenue	2023-01-01 → 2023-12-31	¥84.9bn
—segment total	revenue external	2023-01-01 → 2023-12-31	¥84.9bn
—segment total	revenue intersegment	2023-01-01 → 2023-12-31	¥14m
—segment total	segment assets	at 2023-12-31	¥50.7bn
—segment total	segment profit	2023-01-01 → 2023-12-31	¥3.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,684

Item	Context	Value	Unit
Other ioa	CurrentYearInstant	235000000	JPY
Allowance for doubtful accounts ioa by group	Prior1YearInstant	-5000000	JPY
Allowance for doubtful accounts ioa by group	CurrentYearInstant	-5000000	JPY
Investments and other assets	Prior1YearInstant	4181000000	JPY
Investments and other assets	CurrentYearInstant	4675000000	JPY
Noncurrent assets	Prior1YearInstant	29350000000	JPY
Noncurrent assets	CurrentYearInstant	29563000000	JPY
Assets	Prior1YearInstant	55431000000	JPY
Assets	CurrentYearInstant	55739000000	JPY
Notes and accounts payable trade	Prior1YearInstant	4981000000	JPY
Notes and accounts payable trade	CurrentYearInstant	4928000000	JPY
Electronically recorded obligations operating cl	Prior1YearInstant	2035000000	JPY
Electronically recorded obligations operating cl	CurrentYearInstant	1905000000	JPY
Short term loans payable	Prior1YearInstant	3200000000	JPY
Short term loans payable	CurrentYearInstant	1850000000	JPY
Lease obligations cl	Prior1YearInstant	31000000	JPY
Lease obligations cl	CurrentYearInstant	43000000	JPY
Accounts payable other	Prior1YearInstant	4693000000	JPY
Accounts payable other	CurrentYearInstant	4753000000	JPY
Accrued expenses	Prior1YearInstant	176000000	JPY
Accrued expenses	CurrentYearInstant	185000000	JPY
Accrued alcohol tax	Prior1YearInstant	8240000000	JPY
Accrued alcohol tax	CurrentYearInstant	8249000000	JPY
Accrued consumption taxes	Prior1YearInstant	1289000000	JPY
Accrued consumption taxes	CurrentYearInstant	1032000000	JPY
Income taxes payable	Prior1YearInstant	681000000	JPY
Income taxes payable	CurrentYearInstant	634000000	JPY
Deposits received	Prior1YearInstant	369000000	JPY
Deposits received	CurrentYearInstant	350000000	JPY
Provision for bonuses	Prior1YearInstant	59000000	JPY
Provision for bonuses	CurrentYearInstant	66000000	JPY
Provision for directors bonuses	Prior1YearInstant	38000000	JPY
Provision for directors bonuses	CurrentYearInstant	39000000	JPY
Provision for shareholder benefit program cl	Prior1YearInstant	27000000	JPY
Provision for shareholder benefit program cl	CurrentYearInstant	24000000	JPY
Notes payable facilities	Prior1YearInstant	125000000	JPY
Notes payable facilities	CurrentYearInstant	562000000	JPY
Electronically recorded obligations facilities cl	Prior1YearInstant	86000000	JPY
Electronically recorded obligations facilities cl	CurrentYearInstant	136000000	JPY
Other cl	Prior1YearInstant	254000000	JPY
Other cl	CurrentYearInstant	133000000	JPY
Current liabilities	Prior1YearInstant	26292000000	JPY
Current liabilities	CurrentYearInstant	24897000000	JPY
Long term loans payable	Prior1YearInstant	1800000000	JPY
Long term loans payable	CurrentYearInstant	1200000000	JPY
Long term deposits received	Prior1YearInstant	3164000000	JPY
Long term deposits received	CurrentYearInstant	3182000000	JPY
Lease obligations ncl	Prior1YearInstant	44000000	JPY
Lease obligations ncl	CurrentYearInstant	66000000	JPY
Deferred tax liabilities	Prior1YearInstant	153000000	JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed

balance sheet identity	consolidated 2023-12-31	pass
balance sheet identity	consolidated 2024-12-31	pass rounding
balance sheet identity	non_consolidated 2023-12-31	pass rounding
balance sheet identity	non_consolidated 2024-12-31	pass rounding
dei present		pass
period resolution		pass
statement vs summary · net assets	consolidated 2022-12-31	pass
statement vs summary · net assets	consolidated 2023-12-31	pass
statement vs summary · net assets	consolidated 2024-12-31	pass
statement vs summary · net assets	non_consolidated 2022-12-31	pass
statement vs summary · net assets	non_consolidated 2023-12-31	pass
statement vs summary · net assets	non_consolidated 2024-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2023-01-01/2023-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2024-01-01/2024-12-31	pass
statement vs summary · operating cash flow	consolidated 2023-01-01/2023-12-31	pass
statement vs summary · operating cash flow	consolidated 2024-01-01/2024-12-31	pass
statement vs summary · revenue	consolidated 2023-01-01/2023-12-31	pass
statement vs summary · revenue	consolidated 2024-01-01/2024-12-31	pass
statement vs summary · revenue	non_consolidated 2023-01-01/2023-12-31	pass
statement vs summary · revenue	non_consolidated 2024-01-01/2024-12-31	pass
statement vs summary · total assets	consolidated 2023-12-31	pass
statement vs summary · total assets	consolidated 2024-12-31	pass
statement vs summary · total assets	non_consolidated 2023-12-31	pass
statement vs summary · total assets	non_consolidated 2024-12-31	pass